Webinar · 1:1:50
From Insight to Impact: A Conversation on the Strategic Role of Biomarkers in Drug Discovery and Clinical Trials
Dawn Waterworth, Executive Director Immunology Translational Sciences, Johnson & Johnson Innovative Medicine
Magnus Althage, Head of the Translational Science & Experimental Medicine Strategy Group in CVRM, AstraZeneca R&D
Jen-Chieh Chuang, Director, GPL & Translational Biomarker Lead, Liver Diseases, Takeda Pharmaceuticals
Ray Chen, Global Sr. Director of Strategic Accounts, Olink , part of Thermo Fisher Scientific